Glioblastoma immunotherapy trial: a new breakthrough
All clinical trials are fueled, in part, by optimism. A trial currently underway in California is fueled by the optimism of one patient in particular, Kayvon Goodarzy.
Despite decades of effort, there has been an abject lack of new approved therapies for glioblastoma (GBM). The standard of care for this deadly brain tumor has been chemotherapy and radiation, to less-than-ideal results. But that might be changing, and it’s all thanks …







![AI censorship threatens the lifeline of caregiver support [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)
